BIOHK2026 Successfully Concludes

Nanjing Zhihe made a brilliant appearance at Booth 3E-A09 and looks forward to seeing you again!

Nanjing Zhihe Pharmaceutical Technology Co., Ltd. — Exhibition Recap

On September 9, the BIOHK2026 Hong Kong International Biotech Show grandly opened.

The conference focused on coordinated innovation in the Guangdong-Hong Kong-Macao Greater Bay Area biopharma industry, gathering domestic and overseas pharma companies, research institutes, and investors to build a global life-sciences strategic pivot.

The multi-day exhibition has successfully concluded and Zhihe's Hong Kong trip was rewarding.

At the show, Zhihe (Nanjing Zhihe Pharmaceutical Technology Co., Ltd., Booth 3E-A09) made a strong appearance with one-stop R&D services for innovative and improved drugs.

With its full-chain drug R&D expertise, the booth was constantly busy with inquiries; the team had in-depth exchanges with domestic and overseas partners, with sustained on-site energy.

During the conference, Founder and Chairman Dr. Zhang Zhefeng was invited to deliver a keynote on "Source Innovation and Fast Follow — Zhihe's CNS Innovative Drug Development Strategy."

Focusing on the huge unmet clinical needs in CNS, he shared Zhihe's clinical-need-driven approach.

Centered on stroke, epilepsy, insomnia, pain, Alzheimer's disease, and other directions, the layout of FIC and fast-follow innovative drugs.

Meanwhile, the Zhihe team held one-on-one in-depth exchanges with domestic and overseas pharma companies, research institutes, and investors.

The team had thorough discussions on project collaboration, technology transfer, and internationalization, with a warm and lively atmosphere on site.

Although the exhibition has ended, the cooperation continues.

Thank you to every new and old friend who visited Booth 3E-A09.

Nanjing Zhihe will continue to walk alongside you with professional, efficient R&D services.

We look forward to meeting you again!